ヒトホスホタウ(181P)アッセイキットの世界市場成長 2023-2029Global Human Phospho Tau(181P) Assay Kit Market Growth 2023-2029 弊社(LP Info Research)の最新調査によると、世界のヒトホスホタウ(181P)アッセイキット市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の影響から... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー弊社(LP Info Research)の最新調査によると、世界のヒトホスホタウ(181P)アッセイキット市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の影響からの回復により、ヒトホスホタウ(181P)アッセイキットはレビュー期間中の年平均成長率%で2029年までに百万米ドルの再調整規模になると予測されています。この調査レポートは、世界のヒトホスホタウ(181P)アッセイキット市場の成長可能性を明らかにしています。COVID-19とロシア・ウクライナ戦争の影響からの回復に伴い、ヒトホスホタウ(181P)アッセイキットは今後の市場で安定した成長を示すと予想される。しかし、Human Phospho Tau(181P) Assay Kitの普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要である。市場関係者は、Human Phospho Tau(181P) Assay Kit市場が提供する膨大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要がある。 国内外の多くの研究により、血漿pTau-181はアルツハイマー病(AD)の早期バイオマーカーとして使用でき、AD認知症と非AD認知症の神経変性疾患を効果的に鑑別できることが示されているが、血液の影響により、脳関門の制限により、末梢血中の脳由来タンパク質の濃度は低く、血漿マトリックスタンパク質の干渉を受けやすい。従来のELISA法や化学発光法では理想的な検出結果が得られない。 主な特徴 この調査レポートは、Human Phospho Tau(181P) Assay Kit市場の様々な側面を反映し、業界に対する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、ヒトホスホタウ(181P)アッセイキット市場の現在の規模と成長の概要を提供しています。過去データ、タイプ別市場区分(ELISA法、化学発光法など)、地域別内訳を含む場合があります。 市場促進要因と課題:レポートでは、政府規制、環境問題、技術進歩、消費者の嗜好の変化など、ヒトホスホタウ(181P)アッセイキット市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、測定範囲への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができます。 競合情勢:調査レポートは、ヒトホスホタウ(181P)アッセイキット市場内の競合状況の分析を提供します。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興企業やその市場に与える潜在的な影響にもスポットを当てています。 技術開発:調査レポートは、ヒトホスホタウ(181P)アッセイキット業界における最新の技術開発を掘り下げることができます。これには、ヒトホスホタウ(181P)アッセイキット技術の進歩、ヒトホスホタウ(181P)アッセイキットの新規参入企業、ヒトホスホタウ(181P)アッセイキットの新規投資、ヒトホスホタウ(181P)アッセイキットの将来を形作るその他の技術革新が含まれます。 川下企業の好み:このレポートは、Human Phospho Tau(181P) Assay Kit市場における顧客の購買行動と採用動向を明らかにします。顧客の購買決定、Human Phospho Tau(181P) Assay Kit製品の嗜好に影響を与える要因も含まれます。 政府の政策とインセンティブ調査レポートは、政府の政策とインセンティブがヒトホスホタウ(181P)アッセイキット市場に与える影響を分析します。これには、規制の枠組み、補助金、税制優遇措置、ヒトホスホタウ(181P)アッセイキット市場の促進を目的としたその他の措置の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価する。 環境影響と持続可能性調査レポートは、ヒトホスホタウ(181P)アッセイキット市場の環境への影響と持続可能性の側面を評価します。 市場予測と将来展望:当調査レポートでは、実施した分析に基づいて、ヒトホスホタウ(181P)アッセイキット産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられている。市場関係者が新たなトレンドを活用し、課題を克服し、ヒトホスホタウ(181P)アッセイキット市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場のセグメンテーション ヒトホスホタウ(181P)アッセイキット市場は、タイプ別と用途別に分けられる。2018年~2029年の期間について、セグメント間の成長により、タイプ別、アプリケーション別の消費額の正確な計算と予測を数量と金額で提供します。 タイプ別セグメント ELISA法 化学発光法 用途別セグメント AD認知症 非AD型認知症 また、本レポートでは地域別に市場を分割しています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 ロシュ・ダイアグノスティックス アブカム 富士レビオ 免疫生物学研究所 バイオルート IBLアメリカ レイバイオテック アッセイジーニー ノーバス バイオロジカルズ ライフスパン バイオサイエンス バイオベンダーラボラトリーメディシン リキックス・バイオ アダンチ 上海シグバイオテクノロジー 武漢ファインバイオテクノロジー 本レポートで扱う主な質問 世界のHuman Phospho Tau(181P) Assay Kit市場の10年展望は? ヒトホスホタウ(181P)アッセイキットの世界市場および地域別市場成長の要因は何か? 市場別、地域別で最も急成長する技術は何か? ヒトホスホタウ(181P)アッセイキットの市場機会は最終市場規模によってどのように異なるのか? Human Phospho Tau(181P) Assay Kitのタイプ別、用途別の内訳は? COVID-19とロシア・ウクライナ戦争の影響は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Human Phospho Tau(181P) Assay Kit Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Human Phospho Tau(181P) Assay Kit by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Human Phospho Tau(181P) Assay Kit by Country/Region, 2018, 2022 & 2029 2.2 Human Phospho Tau(181P) Assay Kit Segment by Type 2.2.1 ELISA 2.2.2 Chemiluminescence Method 2.3 Human Phospho Tau(181P) Assay Kit Sales by Type 2.3.1 Global Human Phospho Tau(181P) Assay Kit Sales Market Share by Type (2018-2023) 2.3.2 Global Human Phospho Tau(181P) Assay Kit Revenue and Market Share by Type (2018-2023) 2.3.3 Global Human Phospho Tau(181P) Assay Kit Sale Price by Type (2018-2023) 2.4 Human Phospho Tau(181P) Assay Kit Segment by Application 2.4.1 AD Dementia 2.4.2 Non-AD Dementia 2.5 Human Phospho Tau(181P) Assay Kit Sales by Application 2.5.1 Global Human Phospho Tau(181P) Assay Kit Sale Market Share by Application (2018-2023) 2.5.2 Global Human Phospho Tau(181P) Assay Kit Revenue and Market Share by Application (2018-2023) 2.5.3 Global Human Phospho Tau(181P) Assay Kit Sale Price by Application (2018-2023) 3 Global Human Phospho Tau(181P) Assay Kit by Company 3.1 Global Human Phospho Tau(181P) Assay Kit Breakdown Data by Company 3.1.1 Global Human Phospho Tau(181P) Assay Kit Annual Sales by Company (2018-2023) 3.1.2 Global Human Phospho Tau(181P) Assay Kit Sales Market Share by Company (2018-2023) 3.2 Global Human Phospho Tau(181P) Assay Kit Annual Revenue by Company (2018-2023) 3.2.1 Global Human Phospho Tau(181P) Assay Kit Revenue by Company (2018-2023) 3.2.2 Global Human Phospho Tau(181P) Assay Kit Revenue Market Share by Company (2018-2023) 3.3 Global Human Phospho Tau(181P) Assay Kit Sale Price by Company 3.4 Key Manufacturers Human Phospho Tau(181P) Assay Kit Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Human Phospho Tau(181P) Assay Kit Product Location Distribution 3.4.2 Players Human Phospho Tau(181P) Assay Kit Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Human Phospho Tau(181P) Assay Kit by Geographic Region 4.1 World Historic Human Phospho Tau(181P) Assay Kit Market Size by Geographic Region (2018-2023) 4.1.1 Global Human Phospho Tau(181P) Assay Kit Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Human Phospho Tau(181P) Assay Kit Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Human Phospho Tau(181P) Assay Kit Market Size by Country/Region (2018-2023) 4.2.1 Global Human Phospho Tau(181P) Assay Kit Annual Sales by Country/Region (2018-2023) 4.2.2 Global Human Phospho Tau(181P) Assay Kit Annual Revenue by Country/Region (2018-2023) 4.3 Americas Human Phospho Tau(181P) Assay Kit Sales Growth 4.4 APAC Human Phospho Tau(181P) Assay Kit Sales Growth 4.5 Europe Human Phospho Tau(181P) Assay Kit Sales Growth 4.6 Middle East & Africa Human Phospho Tau(181P) Assay Kit Sales Growth 5 Americas 5.1 Americas Human Phospho Tau(181P) Assay Kit Sales by Country 5.1.1 Americas Human Phospho Tau(181P) Assay Kit Sales by Country (2018-2023) 5.1.2 Americas Human Phospho Tau(181P) Assay Kit Revenue by Country (2018-2023) 5.2 Americas Human Phospho Tau(181P) Assay Kit Sales by Type 5.3 Americas Human Phospho Tau(181P) Assay Kit Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Human Phospho Tau(181P) Assay Kit Sales by Region 6.1.1 APAC Human Phospho Tau(181P) Assay Kit Sales by Region (2018-2023) 6.1.2 APAC Human Phospho Tau(181P) Assay Kit Revenue by Region (2018-2023) 6.2 APAC Human Phospho Tau(181P) Assay Kit Sales by Type 6.3 APAC Human Phospho Tau(181P) Assay Kit Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Human Phospho Tau(181P) Assay Kit by Country 7.1.1 Europe Human Phospho Tau(181P) Assay Kit Sales by Country (2018-2023) 7.1.2 Europe Human Phospho Tau(181P) Assay Kit Revenue by Country (2018-2023) 7.2 Europe Human Phospho Tau(181P) Assay Kit Sales by Type 7.3 Europe Human Phospho Tau(181P) Assay Kit Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Human Phospho Tau(181P) Assay Kit by Country 8.1.1 Middle East & Africa Human Phospho Tau(181P) Assay Kit Sales by Country (2018-2023) 8.1.2 Middle East & Africa Human Phospho Tau(181P) Assay Kit Revenue by Country (2018-2023) 8.2 Middle East & Africa Human Phospho Tau(181P) Assay Kit Sales by Type 8.3 Middle East & Africa Human Phospho Tau(181P) Assay Kit Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Human Phospho Tau(181P) Assay Kit 10.3 Manufacturing Process Analysis of Human Phospho Tau(181P) Assay Kit 10.4 Industry Chain Structure of Human Phospho Tau(181P) Assay Kit 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Human Phospho Tau(181P) Assay Kit Distributors 11.3 Human Phospho Tau(181P) Assay Kit Customer 12 World Forecast Review for Human Phospho Tau(181P) Assay Kit by Geographic Region 12.1 Global Human Phospho Tau(181P) Assay Kit Market Size Forecast by Region 12.1.1 Global Human Phospho Tau(181P) Assay Kit Forecast by Region (2024-2029) 12.1.2 Global Human Phospho Tau(181P) Assay Kit Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Human Phospho Tau(181P) Assay Kit Forecast by Type 12.7 Global Human Phospho Tau(181P) Assay Kit Forecast by Application 13 Key Players Analysis 13.1 Roche Diagnostics 13.1.1 Roche Diagnostics Company Information 13.1.2 Roche Diagnostics Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.1.3 Roche Diagnostics Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Roche Diagnostics Main Business Overview 13.1.5 Roche Diagnostics Latest Developments 13.2 Abcam 13.2.1 Abcam Company Information 13.2.2 Abcam Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.2.3 Abcam Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Abcam Main Business Overview 13.2.5 Abcam Latest Developments 13.3 Fujirebio 13.3.1 Fujirebio Company Information 13.3.2 Fujirebio Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.3.3 Fujirebio Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Fujirebio Main Business Overview 13.3.5 Fujirebio Latest Developments 13.4 Immuno-Biological Laboratories 13.4.1 Immuno-Biological Laboratories Company Information 13.4.2 Immuno-Biological Laboratories Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.4.3 Immuno-Biological Laboratories Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Immuno-Biological Laboratories Main Business Overview 13.4.5 Immuno-Biological Laboratories Latest Developments 13.5 Biorbyt 13.5.1 Biorbyt Company Information 13.5.2 Biorbyt Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.5.3 Biorbyt Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Biorbyt Main Business Overview 13.5.5 Biorbyt Latest Developments 13.6 IBL-America 13.6.1 IBL-America Company Information 13.6.2 IBL-America Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.6.3 IBL-America Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 IBL-America Main Business Overview 13.6.5 IBL-America Latest Developments 13.7 RayBiotech 13.7.1 RayBiotech Company Information 13.7.2 RayBiotech Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.7.3 RayBiotech Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 RayBiotech Main Business Overview 13.7.5 RayBiotech Latest Developments 13.8 Assay Genie 13.8.1 Assay Genie Company Information 13.8.2 Assay Genie Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.8.3 Assay Genie Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Assay Genie Main Business Overview 13.8.5 Assay Genie Latest Developments 13.9 Novus Biologicals 13.9.1 Novus Biologicals Company Information 13.9.2 Novus Biologicals Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.9.3 Novus Biologicals Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Novus Biologicals Main Business Overview 13.9.5 Novus Biologicals Latest Developments 13.10 LifeSpan BioSciences 13.10.1 LifeSpan BioSciences Company Information 13.10.2 LifeSpan BioSciences Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.10.3 LifeSpan BioSciences Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 LifeSpan BioSciences Main Business Overview 13.10.5 LifeSpan BioSciences Latest Developments 13.11 BioVendor Laboratory Medicine 13.11.1 BioVendor Laboratory Medicine Company Information 13.11.2 BioVendor Laboratory Medicine Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.11.3 BioVendor Laboratory Medicine Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 BioVendor Laboratory Medicine Main Business Overview 13.11.5 BioVendor Laboratory Medicine Latest Developments 13.12 Lychix Bio 13.12.1 Lychix Bio Company Information 13.12.2 Lychix Bio Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.12.3 Lychix Bio Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Lychix Bio Main Business Overview 13.12.5 Lychix Bio Latest Developments 13.13 Adanti 13.13.1 Adanti Company Information 13.13.2 Adanti Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.13.3 Adanti Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Adanti Main Business Overview 13.13.5 Adanti Latest Developments 13.14 Shanghai Sig Biotechnology 13.14.1 Shanghai Sig Biotechnology Company Information 13.14.2 Shanghai Sig Biotechnology Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.14.3 Shanghai Sig Biotechnology Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Shanghai Sig Biotechnology Main Business Overview 13.14.5 Shanghai Sig Biotechnology Latest Developments 13.15 Wuhan Fine Biotech 13.15.1 Wuhan Fine Biotech Company Information 13.15.2 Wuhan Fine Biotech Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.15.3 Wuhan Fine Biotech Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Wuhan Fine Biotech Main Business Overview 13.15.5 Wuhan Fine Biotech Latest Developments 14 Research Findings and Conclusion
SummaryAccording to our (LP Info Research) latest study, the global Human Phospho Tau(181P) Assay Kit market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Human Phospho Tau(181P) Assay Kit is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Human Phospho Tau(181P) Assay Kit Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Human Phospho Tau(181P) Assay Kit by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Human Phospho Tau(181P) Assay Kit by Country/Region, 2018, 2022 & 2029 2.2 Human Phospho Tau(181P) Assay Kit Segment by Type 2.2.1 ELISA 2.2.2 Chemiluminescence Method 2.3 Human Phospho Tau(181P) Assay Kit Sales by Type 2.3.1 Global Human Phospho Tau(181P) Assay Kit Sales Market Share by Type (2018-2023) 2.3.2 Global Human Phospho Tau(181P) Assay Kit Revenue and Market Share by Type (2018-2023) 2.3.3 Global Human Phospho Tau(181P) Assay Kit Sale Price by Type (2018-2023) 2.4 Human Phospho Tau(181P) Assay Kit Segment by Application 2.4.1 AD Dementia 2.4.2 Non-AD Dementia 2.5 Human Phospho Tau(181P) Assay Kit Sales by Application 2.5.1 Global Human Phospho Tau(181P) Assay Kit Sale Market Share by Application (2018-2023) 2.5.2 Global Human Phospho Tau(181P) Assay Kit Revenue and Market Share by Application (2018-2023) 2.5.3 Global Human Phospho Tau(181P) Assay Kit Sale Price by Application (2018-2023) 3 Global Human Phospho Tau(181P) Assay Kit by Company 3.1 Global Human Phospho Tau(181P) Assay Kit Breakdown Data by Company 3.1.1 Global Human Phospho Tau(181P) Assay Kit Annual Sales by Company (2018-2023) 3.1.2 Global Human Phospho Tau(181P) Assay Kit Sales Market Share by Company (2018-2023) 3.2 Global Human Phospho Tau(181P) Assay Kit Annual Revenue by Company (2018-2023) 3.2.1 Global Human Phospho Tau(181P) Assay Kit Revenue by Company (2018-2023) 3.2.2 Global Human Phospho Tau(181P) Assay Kit Revenue Market Share by Company (2018-2023) 3.3 Global Human Phospho Tau(181P) Assay Kit Sale Price by Company 3.4 Key Manufacturers Human Phospho Tau(181P) Assay Kit Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Human Phospho Tau(181P) Assay Kit Product Location Distribution 3.4.2 Players Human Phospho Tau(181P) Assay Kit Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Human Phospho Tau(181P) Assay Kit by Geographic Region 4.1 World Historic Human Phospho Tau(181P) Assay Kit Market Size by Geographic Region (2018-2023) 4.1.1 Global Human Phospho Tau(181P) Assay Kit Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Human Phospho Tau(181P) Assay Kit Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Human Phospho Tau(181P) Assay Kit Market Size by Country/Region (2018-2023) 4.2.1 Global Human Phospho Tau(181P) Assay Kit Annual Sales by Country/Region (2018-2023) 4.2.2 Global Human Phospho Tau(181P) Assay Kit Annual Revenue by Country/Region (2018-2023) 4.3 Americas Human Phospho Tau(181P) Assay Kit Sales Growth 4.4 APAC Human Phospho Tau(181P) Assay Kit Sales Growth 4.5 Europe Human Phospho Tau(181P) Assay Kit Sales Growth 4.6 Middle East & Africa Human Phospho Tau(181P) Assay Kit Sales Growth 5 Americas 5.1 Americas Human Phospho Tau(181P) Assay Kit Sales by Country 5.1.1 Americas Human Phospho Tau(181P) Assay Kit Sales by Country (2018-2023) 5.1.2 Americas Human Phospho Tau(181P) Assay Kit Revenue by Country (2018-2023) 5.2 Americas Human Phospho Tau(181P) Assay Kit Sales by Type 5.3 Americas Human Phospho Tau(181P) Assay Kit Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Human Phospho Tau(181P) Assay Kit Sales by Region 6.1.1 APAC Human Phospho Tau(181P) Assay Kit Sales by Region (2018-2023) 6.1.2 APAC Human Phospho Tau(181P) Assay Kit Revenue by Region (2018-2023) 6.2 APAC Human Phospho Tau(181P) Assay Kit Sales by Type 6.3 APAC Human Phospho Tau(181P) Assay Kit Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Human Phospho Tau(181P) Assay Kit by Country 7.1.1 Europe Human Phospho Tau(181P) Assay Kit Sales by Country (2018-2023) 7.1.2 Europe Human Phospho Tau(181P) Assay Kit Revenue by Country (2018-2023) 7.2 Europe Human Phospho Tau(181P) Assay Kit Sales by Type 7.3 Europe Human Phospho Tau(181P) Assay Kit Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Human Phospho Tau(181P) Assay Kit by Country 8.1.1 Middle East & Africa Human Phospho Tau(181P) Assay Kit Sales by Country (2018-2023) 8.1.2 Middle East & Africa Human Phospho Tau(181P) Assay Kit Revenue by Country (2018-2023) 8.2 Middle East & Africa Human Phospho Tau(181P) Assay Kit Sales by Type 8.3 Middle East & Africa Human Phospho Tau(181P) Assay Kit Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Human Phospho Tau(181P) Assay Kit 10.3 Manufacturing Process Analysis of Human Phospho Tau(181P) Assay Kit 10.4 Industry Chain Structure of Human Phospho Tau(181P) Assay Kit 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Human Phospho Tau(181P) Assay Kit Distributors 11.3 Human Phospho Tau(181P) Assay Kit Customer 12 World Forecast Review for Human Phospho Tau(181P) Assay Kit by Geographic Region 12.1 Global Human Phospho Tau(181P) Assay Kit Market Size Forecast by Region 12.1.1 Global Human Phospho Tau(181P) Assay Kit Forecast by Region (2024-2029) 12.1.2 Global Human Phospho Tau(181P) Assay Kit Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Human Phospho Tau(181P) Assay Kit Forecast by Type 12.7 Global Human Phospho Tau(181P) Assay Kit Forecast by Application 13 Key Players Analysis 13.1 Roche Diagnostics 13.1.1 Roche Diagnostics Company Information 13.1.2 Roche Diagnostics Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.1.3 Roche Diagnostics Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Roche Diagnostics Main Business Overview 13.1.5 Roche Diagnostics Latest Developments 13.2 Abcam 13.2.1 Abcam Company Information 13.2.2 Abcam Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.2.3 Abcam Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Abcam Main Business Overview 13.2.5 Abcam Latest Developments 13.3 Fujirebio 13.3.1 Fujirebio Company Information 13.3.2 Fujirebio Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.3.3 Fujirebio Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Fujirebio Main Business Overview 13.3.5 Fujirebio Latest Developments 13.4 Immuno-Biological Laboratories 13.4.1 Immuno-Biological Laboratories Company Information 13.4.2 Immuno-Biological Laboratories Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.4.3 Immuno-Biological Laboratories Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Immuno-Biological Laboratories Main Business Overview 13.4.5 Immuno-Biological Laboratories Latest Developments 13.5 Biorbyt 13.5.1 Biorbyt Company Information 13.5.2 Biorbyt Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.5.3 Biorbyt Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Biorbyt Main Business Overview 13.5.5 Biorbyt Latest Developments 13.6 IBL-America 13.6.1 IBL-America Company Information 13.6.2 IBL-America Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.6.3 IBL-America Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 IBL-America Main Business Overview 13.6.5 IBL-America Latest Developments 13.7 RayBiotech 13.7.1 RayBiotech Company Information 13.7.2 RayBiotech Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.7.3 RayBiotech Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 RayBiotech Main Business Overview 13.7.5 RayBiotech Latest Developments 13.8 Assay Genie 13.8.1 Assay Genie Company Information 13.8.2 Assay Genie Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.8.3 Assay Genie Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Assay Genie Main Business Overview 13.8.5 Assay Genie Latest Developments 13.9 Novus Biologicals 13.9.1 Novus Biologicals Company Information 13.9.2 Novus Biologicals Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.9.3 Novus Biologicals Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Novus Biologicals Main Business Overview 13.9.5 Novus Biologicals Latest Developments 13.10 LifeSpan BioSciences 13.10.1 LifeSpan BioSciences Company Information 13.10.2 LifeSpan BioSciences Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.10.3 LifeSpan BioSciences Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 LifeSpan BioSciences Main Business Overview 13.10.5 LifeSpan BioSciences Latest Developments 13.11 BioVendor Laboratory Medicine 13.11.1 BioVendor Laboratory Medicine Company Information 13.11.2 BioVendor Laboratory Medicine Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.11.3 BioVendor Laboratory Medicine Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 BioVendor Laboratory Medicine Main Business Overview 13.11.5 BioVendor Laboratory Medicine Latest Developments 13.12 Lychix Bio 13.12.1 Lychix Bio Company Information 13.12.2 Lychix Bio Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.12.3 Lychix Bio Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Lychix Bio Main Business Overview 13.12.5 Lychix Bio Latest Developments 13.13 Adanti 13.13.1 Adanti Company Information 13.13.2 Adanti Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.13.3 Adanti Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Adanti Main Business Overview 13.13.5 Adanti Latest Developments 13.14 Shanghai Sig Biotechnology 13.14.1 Shanghai Sig Biotechnology Company Information 13.14.2 Shanghai Sig Biotechnology Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.14.3 Shanghai Sig Biotechnology Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Shanghai Sig Biotechnology Main Business Overview 13.14.5 Shanghai Sig Biotechnology Latest Developments 13.15 Wuhan Fine Biotech 13.15.1 Wuhan Fine Biotech Company Information 13.15.2 Wuhan Fine Biotech Human Phospho Tau(181P) Assay Kit Product Portfolios and Specifications 13.15.3 Wuhan Fine Biotech Human Phospho Tau(181P) Assay Kit Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Wuhan Fine Biotech Main Business Overview 13.15.5 Wuhan Fine Biotech Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポートLP Information社の医療分野での最新刊レポート本レポートと同じKEY WORD(assay)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |